Clinical Trials Current Events | Clinical Trials News | 10
|
| Page
10 of
46 |
902 Results |
|
|
|
Sort By:
Page Views | Date |
National report shines light on lupus 50-year treatment drought
Today, The Lewin Group, a national health care consulting firm, issued recommendations on ways to overcome the barriers that have obstructed lupus drug development resulting in no new drug approval for this disease in more than 50 years - since the Eisenhower Administration. view more (2009-10-05)
Adult stem cells may be beneficial for certain cardiovascular disorders and autoimmune diseases
A review of previously published research suggests that stem cells harvested from an adult's blood or marrow may provide treatment benefit to select patients for some autoimmune diseases and cardiovascular disorders. view more (2008-02-27)
NICE SUGAR: Intensive insulin therapy risks
Intensive insulin therapy significantly increases the risk of hypoglycemia in critically ill patients. view more (2009-03-24)
Massive necrosis after trans-catheter treatment is more common in the presence of tumor capsule
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. Prognosis of patients with HCC complicating cirrhosis mainly depends on the tumor growth, progression of the underlying liver disease and the effectiveness of antitumoral treatment. view more (2007-11-26)
Heart catheters do not benefit patients
Doctors should probably stop using pulmonary artery catheters because they do not benefit patients, say doctors from Australia in this week's BMJ. view more (2006-11-03)
Post-marketing studies finding adverse events in drugs used in children
The Food and Drug Administration Modernization Act (FDAMA, 1997), designed to stimulate more drug safety studies in children, has resulted in more than 130 label changes since its inception nearly six years ago, according to researchers at Duke Children's Hospital. view more (2008-09-02)
Invitation to the Press - Heart Failure Update 2002, 8-11 June 2002, Oslo
Heart Failure Update 2002, `From Damage to Defence`, is soon to take place in Oslo, Norway, from 8-11 June 2002 and is the official update meeting of the ESC Working Group on Heart Failure, The meeting will present an update on all aspects of heart failure from basic research to clinical care. Key features of the scientific programme will include:... view more... (2002-05-28)
New lab test offers better prediction of HIV microbicide safety
Scientists at Albert Einstein College of Medicine of Yeshiva University have devised a laboratory test for predicting whether microbicides against HIV are safe for human use. view more (2009-07-10)
BUSM researchers propose a relationship between androgen deficiency and cardiovascular disease
Researchers from Boston University School of Medicine (BUSM) in collaboration with researchers from Lahey Clinic Northshore, Peabody, Mass., believe that androgen deficiency might be the underlying cause for a variety of common clinical conditions, including diabetes, erectile dysfunction, metabolic syndrome and cardiovascular disease (CVD). view more (2009-09-28)
ACE inhibitors may reduce death, heart attack and stroke in patients with coronary artery disease
ngiotension-converting enzyme (ACE) inhibitors, medications commonly used to treat hypertension (high blood pressure), may reduce cardiovascular risk and the risk of death in patients with coronary artery disease. view more (2006-04-11)
Results from the European CRT survey
The European cardiac resynchronization therapy (CRT) Survey is a joint initiative taken by the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology. view more (2009-09-01)
Conflict of interest in psychopharmacology: can dr Jekyll still control Mr Hyde?
Giovanni A. Fava (Professor of Clinical Psychology at the University of Bologna) comments on several issues rising from the Nemeroff affair (the scandal following failure of disclose conflict of interest in an article that appeared in Nature Neuroscience). The main point is the fact that one scientist start earning amounts of money from... view more... (2004-01-12)
Enzyme inhibitor produces stable disease in patients with advanced solid cell cancers
Preliminary trials of a MEK enzyme inhibitor have shown that it is capable of producing long-lasting stable disease in patients with advanced solid cancers. Tests showed that the drug inhibited key targets in the patients' tumours, and now it is being tested in phase II clinical trials. view more (2006-11-08)
Stem cells as cancer therapy
It is widely hoped that neural stem cells will eventually be useful for replacing nerves damaged by degenerative diseases like Alzheimer disease and multiple sclerosis. But there may also be another use for such stem cells-delivering anti-cancer drugs to cancer cells. view more (2006-12-26)
50 percent of recent onset RA patients become free of signs and symptoms within 36 weeks
At least 50% of recent onset rheumatoid arthritis patients achieve remission (a state free of signs and symptoms) within 36 weeks when following a systematic approach of step-up DMARD treatment in combination with tight control. view more (2008-06-12)
Fox Chase finds all-biologic regimen efficacious and well-tolerated in elderly lung cancer patients
Previously untreated non-small cell lung cancer (NSCLC) patients over the age of 70 respond well to a combination of bevacizumab and erlotinib, Fox Chase Cancer Center researchers reported today at the annual meeting of the International Association for the Study of Lung Cancer. view more (2009-08-03)
Colon Cancer Screening Technique Shows Continued Promise in New Study
Recent clinical trials show that a new colon cancer screening technique created by Northwestern University researchers has a high enough sensitivity that it could potentially be as or more successful than a colonoscopy in screening for colon cancer. view more (2009-06-10)
Perth researchers to trial bird flu vaccine
Perth researchers have begun a trial to test the effectiveness of a new vaccine to protect against the potentially deadly bird flu. view more (2006-06-29)
A new pharmaceutical drug that halts progress of metastatic kidney cancer
Research has shown the efficacy of a pharmaceutical drug known as sunitinib which halts progress of metastatic kidney cancer. view more (2007-03-02)
Budesonide is not beneficial for the treatment of diarrhea in metastatic melanoma patients
Patients with stage III or IV melanoma taking ipilimumab and the oral steroid budesonide to reduce side effects did not have less diarrhea, a known side effect of ipilimumab. view more (2009-08-12)
|
|
| Page
10 of
46 |
902 Results |
|
|
|
Sort By:
Page Views | Date |
|
